Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522-Reference-Cited by-同舟云学术

Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522

Published:2017-03 Issue:4 Volume:97 Page:687-699
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Truong Minh Tam,Zhang Qiang,Rosenthal David I.,List Marcie,Axelrod Rita,Sherman Eric,Weber Randal,Nguyen-Tân Phuc Felix,El-Naggar Adel,Konski André,Galvin James,Schwartz David,Trotti Andy,Silverman Craig,Singh Anurag,Godette Karen,Bonner James A.,Jones Christopher U.,Garden Adam S.,Shenouda George,Matthiesen Chance,Le Quynh-Thu,Bruner Deborah

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference20 articles.

1. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

2. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: A prospective examination;List;J Clin Oncol,1999

3. Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer;List;Qual Life Res,1997

4. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: Prospective study of patient-reported, observer-rated, and objective outcomes;Hunter;Int J Radiat Oncol Biol Phys,2013

5. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N Engl J Med,2010

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A scoping review of utilisation of the EQ-5D questionnaire to evaluate health-related quality of life following a diagnosis of head and neck cancer;Frontiers of Oral and Maxillofacial Medicine;2024-03

2. De-escalation for Human Papillomavirus–Associated Oropharyngeal Cancer;Advances in Oncology;2023-05

3. The Inconsistent Assessment of Quality of Life in Patients Treated for Head and Neck Cancer with Anti-EGFR Inhibitors: A Systematic Scoping Review;Cancers;2023-04-26

4. EGFR/Notch antagonists enhance the response to inhibitors of the PI3K-Akt pathway by decreasing tumor-initiating cell frequency;Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies;2023

5. Patient reported outcomes based on EQ-5D-5L questionnaires in head and neck cancer patients: a real-world study;BMC Cancer;2022-11-29